Geri Dön

The molecular pathologies of BRCA1 in ovarian cancer patients from the West of Scotland

Başlık çevirisi mevcut değil.

  1. Tez No: 400440
  2. Yazar: AHMET DURSUN
  3. Danışmanlar: DR. GEORGE LANYON
  4. Tez Türü: Doktora
  5. Konular: Patoloji, Radyasyon Onkolojisi, Pathology, Radiation Oncology
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 2001
  8. Dil: İngilizce
  9. Üniversite: The Unıversıty Of Glasgow
  10. Enstitü: Yurtdışı Enstitü
  11. Ana Bilim Dalı: Patoloji Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: Belirtilmemiş.

Özet

Özet yok.

Özet (Çeviri)

Ovarian cancer is one of the most common female malignancies and is the forth leading cause of cancer death in the western world. It is estimated that 3-13% of all ovarian cancers are familial and the tumour suppressor gene, BRCA1, is responsible for almost 90% of all these familial cases.BRCA1 is a tumour suppressor gene which spans 100 kb on chromosome 17q21 and contains 24 exons. The 7.8 kb mRNA encodes a protein of 1863 amino acids. The structure of BRCA1 is not strikingly homologous to other known molecules apart from the presence of a ring zinc finger domain and a 10 amino acid granin motif which are thought to be significant due to fact that they both are conserved in humans and other species studied.The overall aims of this study were to screen and characterise mutations in the BRCA1 gene using genomic DNA obtained from ovarian cancer patients from the West of Scotland. As a result of the information obtained from this study, genetic counselling would be possible for those who have inherited the mutations and for those who have a high risk of developing the same condition. In this study, 48 ovarian cancer patients with a family history of breast and/or ovarian cancer were screened for germline mutations in the BRCA1 gene.The strategy for germline mutation analysis involved the initial amplification of the BRCA1 gene by polymerase chain reaction (PCR) using genomic DNA as a template. After initial xxamplification, the product was electrophoresed in an 1% agarose gel in order to check for any abnormal alteration in size, quality and quantity of product. If no alteration was identified, further screening of the gene was carried out using the single strand conformational analysis (SSCP) and the protein truncation test (PTT). Any differences in the band pattern, when compared with negative controls (in both techniques) were fully characterised by automated DNA sequencing analysis.Using the strategy described above, 5 different alterations were detected on analysis of BRCA1 coding sequences. Of these, two were novel missense mutations, two were polymorphisms and one was an unclassified variant.The first novel missense mutation was g.3771 A>T, changing serine to cysteine at amino acid position 1218. This mutation is in the granin site at the amino acid positions 1214-1223 and the leucine zipper at amino acid positions 1209-1230. It is well known that cysteine has a very important role in stabilising the three-dimensional protein structure. Two cysteine residues in different parts of the polypeptide chain but adjacent in the three-dimensional structure of a protein can be oxidised to form a disulfide bridge. Disulfide bridges usually occur among secreted proteins and make them less susceptible to degradation.The second novel missense mutation was g.1380 G>A, changing glutamic acid to lysine at the amino acid position 421. This mutation?s effect on the BRCA1 protein is unknown. However, this amino acid is conserved in the murine BRCA1sequence. Two different polymorphisms were also detected in BRCA1 coding sequence.Patient no 28 is thought to be homozygous for polymorphism g.3667 A>G was also checked for possible large deletion within the exon 11.The first polymorphism, g.3667 A>G, was found in four out of forty-eight patients and the second polymorphism, g.4427 T>C, was found in six out of forty-eight patients. These two polymorphisms are the most frequently found in ovarian cancer cases and the normal population. Although, the polymorphisms are generally thought to be a variation in the gene sequence, histopathological studies suggest that the aggressiveness of tumour progress, histological type and survival rate may be related to the host variation.In order to establish the normal population frequency, one hundred samples from normal population was also screened. Six out of one hundred for polymorphism g.3667 A>G and 10 out of 100 for polymorphism g.4427 T>C were found positive for these polymorphisms.An insertion of 12 bp of DNA was also found in intron 20 (5?-GTATTCCACTCC-3?) at IVS20+60. Three studies suggested that this variant is not present in any of the subject in the control population analysed. It was also reported that this variant did not modify the correct splicing of exon 19-21 by analysing the cDNA obtained from the patient?s peripheral blood. It is possible that a relatively large insertion in a region of non-repetitive DNA might affect the kinetics of splicing and result in a lower level of normal mRNA from the mutant allele.

Benzer Tezler

  1. The relationship between BRCA1, HER2, TP53 genes of breast cancer diagnostic

    Meme kanseri teşhisli kadınlarda BRCA1, HER2, TP53 genleri arasındaki ilişki: Musul, Irak'ta örnek bir çalışma

    RABAB ABDULJABBAR ABDULMAJEED

    Yüksek Lisans

    İngilizce

    İngilizce

    2023

    BiyolojiÇankırı Karatekin Üniversitesi

    Biyoloji Ana Bilim Dalı

    DOÇ. DR. IRMAK POLAT

    DOÇ. DR. MOZAHİM KASSİM AL-MALLAH

  2. İnvaziv meme karsinom olgularında her2 ekpresyonunun sısh (gümüş insitu hibridizasyon)yöntemiyle tespit edilerek sonuçların immünohistokimyasal ve fısh (floresan insitu hibridizasyon) yöntemleriyle karşılaştırılması

    Determination of her2 status in invasive ductal breast carcinoma using sish and correlation between fish and ihc

    BETÜL ÜNAL

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2011

    PatolojiAkdeniz Üniversitesi

    Tıbbi Patoloji Ana Bilim Dalı

    PROF. DR. FATMA ŞEYDA KARAVELİ

  3. Meme kanseri dokularında yüksek riskli HPV varlığı ve meme kanseri gelişiminde HPV'nin etkisinin araştırılması

    Başlık çevirisi yok

    EREN KAYA

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2023

    Kadın Hastalıkları ve DoğumAcıbadem Mehmet Ali Aydınlar Üniversitesi

    Kadın Hastalıkları ve Doğum Ana Bilim Dalı

    PROF. DR. SERKAN ERKANLI

  4. Deneysel nekrotizan enterokolit modelinde düşük molekül ağırlıklı heparinin etkisi

    The effect of low molecular heparin in experimental necrotizing enterocolitis model

    ÖZLEM TEPRET

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2012

    Çocuk Cerrahisiİstanbul Üniversitesi

    Çocuk Cerrahisi Ana Bilim Dalı

    PROF. DR. FAİK TANSU SALMAN